Immunovant, Inc. · NASDAQ:IMVT
Fromkin Andrew J. sold 221,951 Immunovant, Inc. shares (Form 4)
Traded May 28, 2026 · Filed May 29, 2026
On May 28, 2026, Fromkin Andrew J. (Director) sold 221,951 Immunovant, Inc. shares at an average US$33.51 for US$7.44M, leaving 74,382 shares. Filed May 29, 2026 (Form 4).
- Sold
- 221,951 shares
- Price
- US$33.51 average (US$32.64 to US$33.56)
- Value
- US$7.44M
- Holding after
- 74,382 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 28, 2026 | Common Stock | Option exercise | 31,668 | US$4.99 | 131,400 | Direct |
| May 28, 2026 | Common Stock | Option exercise | 71,492 | US$7.94 | 202,892 | Direct |
| May 28, 2026 | Common Stock | Option exercise | 77,181 | US$8.43 | 280,073 | Direct |
| May 28, 2026 | Common Stock | Option exercise | 16,260 | US$14.70 | 296,333 | Direct |
| May 28, 2026 | Common Stock | Sale | 11,483 | US$32.64 | 284,850 | Direct |
| May 28, 2026 | Common Stock | Sale | 210,468 | US$33.56 | 74,382 | Direct |